
Lemonade Inc (NYSE: LMND)
Lemonade Inc (NYSE: LMND) provides insurance products across multiple categories, including renters, homeowners, auto, pet, and life insurance. The company operates in both the United States and Europe, including the United Kingdom, utilizing diverse distribution channels to reach its customers.
As per our previous Kalkine’s Diversified Opportunities Report published on ‘LMND’ on 26th June, 2025, Kalkine provided an ‘Buy’ stance on the stock at USD 41.10 based on fundamental analysis and the stock price has now moved by ~ 16.76% since then and is hovering around resistance 2.
Noted below are the details of support and resistance levels provided in our previous report:

Rationale – Sell at USD 47.99
Valuation (Using P/B Multiple)

Share Price Chart

Conclusion
Lemonade Inc. continues to face mounting financial and operational challenges despite its top-line growth. The company’s net losses have widened significantly, fueled by surging operating expenses and strategic but costly growth initiatives. Persistent negative cash flow, declining customer retention, and shrinking profit margins further highlight inefficiencies. Elevated loss ratios—particularly in its car insurance segment—combined with a delayed profitability outlook through 2026, underscore concerns about the company’s sustainability and its ability to deliver long-term shareholder value.
Based on the notional gains, valuation downside and price action stance, a "Sell" recommendation on Lemonade Inc (NYSE: LMND) has been given at the current market price of USD 47.99 as on 05 August 2025 at 8:00 am PDT.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is 05 August 2025. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.
Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.
Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’
Note 6: Dividend Yield may vary as per the stock price movement.
Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.
Past performance is not a reliable indicator of future performance.